Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of

Drug
single
Indication
Neovascular Age-Related Macular Degeneration (nAMD)

Other upcoming events for FDMT

Phase 2 ReadoutPhase 2 Readout: 150

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of — FDMT Phase 3 Readout | BioSniper